Researchers have found in a secondary analysis of a clinical trial published in Obesity that taking dapagliflozin 10 mg daily ...

The FDA granted zongertinib Breakthrough Therapy Designation for patients with HER2 (ERBB2)-mutant advanced NSCLC as an initial treatment. The FDA also awarded a Commissioner's National Priority ...

A woman in her late 20s presented with a 5-year history of progressive fatigue and generalised weakness. Examination revealed signs of premature ageing, anaemia, neuropathy and hepatosplenomegaly.

Scientists from the University of California at San Francisco have identified a mechanism explaining how physical activity ...

-- First of two Pivotal Efficacy Studies support future sNDA submission for Treatment of Pulmonary Anthrax -- Oral NUZYRA Tablets Produced in the U.S. as a Result of the Company's Onshoring Initiative ...

The BRAFTOVI combination regimen is the only approved targeted regimen for first-line BRAF-V600E mutant metastatic colorectal cancerPivotal results from the Phase 3 portion with mFOLFOX6 of the ...

Reflecting its evolution from a diabetes clinic into a full-spectrum metabolic health platform powered by a hybrid “Metabolic OS” ...

A new study suggests preeclampsia, a deadly pregnancy disorder, may have contributed to Neanderthal extinction.

Health influencers promise an astonishing range of benefits from peptides, almost none of them tested in humans ...

Tech tycoons, podcast bros and Hollywood stars are all piling money into full-body scans, which deploy AI in the hope of catching everything from high cholesterol to cancer. Is this the first step to ...

The Advocate highlights social inequality through original stories and opinions, and content generated by fellow NNPA and other publications ...

This edited article originally appeared on Dr. Arif Hussenbux's Substack, The Gut Group. Sign up here.Every week I sit across from patients who tell me about their "comfort foods" and weekend ...